# Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer

> **NCT00008216** · — · TERMINATED · sponsor: **Columbia University** · enrollment: 48 (actual)

## Conditions studied

- Adult Langerhans Cell Histiocytosis
- Childhood Langerhans Cell Histiocytosis
- Leukemia
- Lymphoma
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms

## Interventions

- **PROCEDURE:** Peripheral Blood Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT00008216
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 1996-07
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 48 (ACTUAL)
- **Why stopped:** Poor enrollment
- **Last updated:** 2014-06-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00008216

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00008216, "Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00008216. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*